Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Leukemia, Myeloid, Acute 4Hematologic Neoplasms 4Melanoma 3Lymphoma 3Sarcoma 2Recurrence 2Osteosarcoma 2Neuroblastoma 2Neoplasms 2Myelodysplastic Syndromes 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia, Lymphoid 2Leukemia, B-Cell 2Leukemia 2Wilms Tumor 1Teratoma 1Sarcoma, Ewing 1Sarcoma, Clear Cell 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Preleukemia 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Neurofibrosarcoma 1Neoplasms, Germ Cell and Embryonal 1Neoplasms by Histologic Type 1Meningeal Neoplasms 1Lymphoproliferative Disorders 1Lymphoma, Non-Hodgkin 1

Interventions

Cyclophosphamide 5fludarabine phosphate 3Methotrexate 3merphos 2fludarabine 2Whole-Body Irradiation 2Thiotepa 2Tacrolimus 2Rituximab 2Mycophenolic Acid 2venetoclax 1tagraxofusp 1prednylidene 1exifone 1dexamethasone acetate 1dexamethasone 21-phosphate 1deltacortene 1azathiopurine 1auricularum 1Vincristine 1Sirolimus 1Prednisone 1Peripheral Blood Stem Cell Transplantation 1Methylprednisolone 1Mesna 1Mercaptopurine 1Medrol Veriderm 1Doxorubicin 1Dexamethasone 1Cytarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Blastic Plasmacytoid Dendritic Cell Neoplasm × Mesna × 90 days × Clear all
NCT04318678 2026-05-19

CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)

St. Jude Children's Research Hospital

Phase 1 Recruiting
108 enrolled
LymphoidMyeloidOther hematologic neoplasm

Blastic Plasmacytoid Dendritic Cell Neoplasm, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡